Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.
Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.
复制标题
给编辑的信：对 Bahorik 等人的批评。
DOI：
10.1017/s0033291713002511
复制
发表时间：
2014
影响因子：
6.9
通讯作者：
Sellers,BrianG
中科院分区：
文献类型：
--
作者：
VanDorn,RichardA;Desmarais,SarahL;Swartz,MarvinS;Young,MScott;Sellers,BrianG
科学共识表明，患有严重精神疾病（包括精神分裂症）的成年人可以有效可靠地自我报告（Swanson et al. 2006; Lincoln et al. 2010; Baumstarck et al. 2013）心理、认知和行为功能，包括药物使用（Wolford et al. 1999）。Bahorik和他的同事（2013）不同意这一观点，他们得出结论，在临床抗精神病药物干预有效性试验（CATIE）研究中，精神分裂症成年患者的药物使用情况明显不足。然而，有理由质疑他们的发现。
Scientific consensus indicates that adults with serious mental illnesses, including schizophrenia, can validly and reliably self-report (Swanson et al. 2006; Lincoln et al. 2010; Baumstarck et al. 2013) intra-psychic, cognitive, and behavioural functioning, including drug use (Wolford et al. 1999). Bahorik and colleagues (2013) depart from this viewpoint, concluding that adults with schizophrenia significantly under-reported drug use in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. However, there are reasons to question their findings.